Episodebeskrivelse
Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode!
In this episode of Pharma Explained, we look at a draft rule from China that could stop its companies from selling the core toolkits behind some of the newest medicines to foreign buyers. These toolkits, called platforms, can turn out many drugs and not just one, which is why they matter so much. We explain what the draft says, what it still allows, and why law firms are already busy. We also look at a parallel move in Washington, and what the squeeze from both sides could mean for…
Website: rss.com

